Cardlytics (NASDAQ:CDLX) reported Q1 EPS of ($0.38), $0.17 better than the analyst estimate of ($0.55). Revenue for the quarter came in at $67.9 million versus the consensus estimate of $64.66 million.
GUIDANCE:
Cardlytics sees Q2 2022 revenue of $73-80 million, versus the consensus of $74.7 million.